In cutaneous T cell lymphoma (CTCL), especially in its incurable and aggressive leukemic variant, the Sézary syndrome, there is constitutive NF-κB activation. The gene discussed is NFKB1; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.